• ChemoMetec’s board launched a share buyback program under the mandate granted at the Oct. 8 annual general meeting.
• Up to 500,000 shares, or 2.9% of share capital, may be repurchased for a maximum consideration of DKK 100 million.
• The program runs from Oct. 12, 2026 through March 5, 2027, aimed at adjusting the company’s capital structure.
• Danske Bank will execute trades independently, with discretion to explore block purchases from major shareholders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ChemoMetec A/S published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.